Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center.
bioinformatics
cancer
comprehensive cancer genome profiling
genomics
target therapy
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
20 Oct 2022
20 Oct 2022
Historique:
received:
23
09
2022
revised:
13
10
2022
accepted:
19
10
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
28
10
2022
Statut:
epublish
Résumé
The implementation of cancer molecular characterization in clinical practice has improved prognostic re-definition, extending the eligibility to a continuously increasing number of targeted treatments. Broad molecular profiling technologies better than organ-based approaches are believed to serve such dynamic purposes. We here present the workflow our institution adopted to run a comprehensive cancer genome profiling in clinical practice. This article describes the workflow designed to make a comprehensive cancer genome profiling program feasible and sustainable in a large-volume referral hospital.
Identifiants
pubmed: 36294885
pii: jpm12101746
doi: 10.3390/jpm12101746
pmc: PMC9605534
pii:
doi:
Types de publication
Journal Article
Langues
eng
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
J Clin Oncol. 2018 Aug 1;36(22):2244-2250
pubmed: 29864379
N Engl J Med. 2019 May 16;380(20):1929-1940
pubmed: 31091374
Per Med. 2017 Mar;14(2):141-152
pubmed: 29754553
Lancet. 2015 Aug 1;386(9992):444-51
pubmed: 26037941
N Engl J Med. 2018 Nov 22;379(21):2027-2039
pubmed: 30280657
Am J Cancer Res. 2015 Aug 15;5(9):2892-911
pubmed: 26609494
Nat Rev Clin Oncol. 2018 Dec;15(12):731-747
pubmed: 30333516
Ann Oncol. 2019 May 1;30(5):672-705
pubmed: 31046081
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
N Engl J Med. 2014 Nov 20;371(21):1963-71
pubmed: 25264305
JCO Precis Oncol. 2018;2018:
pubmed: 30051098
Nat Med. 2022 Apr;28(4):658-665
pubmed: 35440717
J Clin Oncol. 2010 Mar 1;28(7):1247-53
pubmed: 20124181
JAMA. 2012 Mar 28;307(12):1265-72
pubmed: 22453568
J Clin Oncol. 2015 Mar 1;33(7):692-700
pubmed: 25605843
Ann Oncol. 2015 Jan;26(1):13-21
pubmed: 25115304
Lancet Oncol. 2020 Feb;21(2):271-282
pubmed: 31838007
Hum Mutat. 2008 Nov;29(11):1282-91
pubmed: 18951446
J Clin Oncol. 2015 Dec 20;33(36):4276-83
pubmed: 26573069
N Engl J Med. 2018 Jan 11;378(2):113-125
pubmed: 29151359
Ann Oncol. 2017 Jul 01;28(7):1631-1639
pubmed: 28475671
Lancet Oncol. 2018 Oct;19(10):1315-1327
pubmed: 30219628
Ann Oncol. 2020 Nov;31(11):1491-1505
pubmed: 32853681
Lancet Oncol. 2015 Jul;16(7):830-8
pubmed: 26051236
J Clin Oncol. 2008 Feb 1;26(4):620-5
pubmed: 18235121
N Engl J Med. 2020 Jan 2;382(1):41-50
pubmed: 31751012
N Engl J Med. 2019 Oct 24;381(17):1632-1643
pubmed: 31566309
Lancet Oncol. 2016 Sep;17(9):1248-60
pubmed: 27480103
JAMA Oncol. 2017 May 01;3(5):602-609
pubmed: 28334365
N Engl J Med. 2017 Nov 9;377(19):1813-1823
pubmed: 28891408
N Engl J Med. 2015 Jan 1;372(1):30-9
pubmed: 25399551
N Engl J Med. 2018 Feb 22;378(8):731-739
pubmed: 29466156
J Clin Oncol. 2018 Aug 1;36(22):2251-2258
pubmed: 29768118
J Clin Oncol. 2014 May 20;32(15):1563-70
pubmed: 24638003
Lancet. 2017 Mar 4;389(10072):917-929
pubmed: 28126333
N Engl J Med. 2017 Aug 31;377(9):829-838
pubmed: 28586279
Ann Surg. 2013 Sep;258(3):422-9
pubmed: 23860199
Lung Cancer. 2018 Nov;125:265-272
pubmed: 30429031
N Engl J Med. 2019 Jul 25;381(4):317-327
pubmed: 31157963
J Mol Diagn. 2017 Jan;19(1):4-23
pubmed: 27993330
N Engl J Med. 2017 Feb 16;376(7):629-640
pubmed: 27959700
Int J Gynecol Cancer. 2021 Jan;31(1):12-39
pubmed: 33397713
Lancet. 2009 Mar 28;373(9669):1097-104
pubmed: 19303137
Lancet Oncol. 2018 May;19(5):603-615
pubmed: 29573941
Cancer Cell. 2017 Aug 14;32(2):185-203.e13
pubmed: 28810144
J Clin Oncol. 2008 Feb 1;26(4):626-32
pubmed: 18235122
Lancet Oncol. 2016 Jul;17(7):984-993
pubmed: 27283860
Ann Oncol. 2019 Jul 1;30(7):1121-1126
pubmed: 30980071
N Engl J Med. 2020 May 28;382(22):2091-2102
pubmed: 32343890
J Clin Oncol. 2020 Feb 10;38(5):488-495
pubmed: 31825714
Lancet Oncol. 2017 Oct;18(10):1307-1316
pubmed: 28919011
Lancet Oncol. 2020 Apr;21(4):531-540
pubmed: 32105622
J Clin Oncol. 2017 May 20;35(15):1713-1720
pubmed: 28362562
N Engl J Med. 2002 Aug 15;347(7):472-80
pubmed: 12181401
N Engl J Med. 2020 Aug 27;383(9):825-835
pubmed: 32846061
Lancet Oncol. 2020 Feb;21(2):261-270
pubmed: 31838015
N Engl J Med. 2014 Nov 13;371(20):1867-76
pubmed: 25265494
Genet Med. 2022 Jul;24(7):1407-1414
pubmed: 35802134
N Engl J Med. 2013 Sep 12;369(11):1023-34
pubmed: 24024839